Information about De Laere Pharma
My details
*
*
*

De Laere Pharma (SRL)

BE 0763.546.683

Nieuwe Ydelaan(Odk) 38, 8670 Koksijde

Company information

Status
Active

Enterprise number

BE0763.546.683

VAT liability
Yes
Established
12-02-2021
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from De Laere Pharma

2024 2023 2022 2021
Profit/Loss € 13,298 12 % € 11,922 -43 % € 21,045 58 % € 13,328
Equity € 26,293 -45 % € 47,995 33 % € 36,073 128 % € 15,828
Gross margin € 19,153 12 % € 17,157 -40 % € 28,454 53 % € 18,611

Publications from De Laere Pharma

Date Publication
26-06-2024 Registered Office (NL)
04-08-2022 Resignations - Appointments (NL)
16-02-2021 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of De Laere Pharma?
The VAT number of De Laere Pharma is BE 0763.546.683.
Wat is the PEPPOL ID of De Laere Pharma?
The PEPPOL ID of De Laere Pharma is 0208:0763546683. Log in or start a free trial to see the full overview.
When was De Laere Pharma founded?
De Laere Pharma was founded on 12-02-2021.
What is the address of De Laere Pharma?
The current registered office of De Laere Pharma is located at Nieuwe Ydelaan(Odk) 38, 8670 Koksijde.
When was the last time De Laere Pharma filed their annual financial statements?
The most recent financial statements of De Laere Pharma were filed on 25-06-2025.
How many employees does De Laere Pharma have?
There are currently no employees working at De Laere Pharma or no workforce information is available.
What is the annual turnover of De Laere Pharma?
At the time of its most recent financial statements, De Laere Pharma did not publish any turnover figures. De Laere Pharma reported a gross margin of €19,153.48.

Sources